MétaCan
Menu
Back to cohort
Record W7034040323

A study on the comparative and combinatorial efficacy of resveratrol with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker/neprilysin inhibitor in myocardial infarction

2019· dissertation· en· W7034040323 on OpenAlexaff

Bibliographic record

VenueMspace (University of Manitoba) · 2019
Typedissertation
Languageen
FieldEngineering
TopicAdvancements in Semiconductor Devices and Circuit Design
Canadian institutionsUniversity of Manitoba
Fundersnot available
KeywordsMyocardial infarctionACE inhibitorHeart failureResveratrolValsartanAngiotensin-converting enzyme
DOInot available

Abstract

fetched live from OpenAlex

Myocardial infarction (MI) and heart failure are the two major health care burdens around the world. Resveratrol, a plant polyphenol, is well-documented for its benefits in the setting of MI. However, it is also important to understand the comparative and combinatorial efficacy of resveratrol alongside the established therapies to translate the pre-clinical findings to the clinical setting. In the first study, left anterior descending coronary artery ligated (MI-induced) and sham-operated male Sprague Dawley rats were treated with vehicle, resveratrol, angiotensin-converting enzyme inhibitor perindopril, or a combination of both for 8 weeks. Echocardiography was performed to assess the cardiac structure and function. MI rats treated with resveratrol, perindopril and a combination of both had significantly reduced left ventricular (LV) dilatation and improved LV ejection fraction (LVEF). Resveratrol, perindopril and a combination of both significantly decreased cardiac oxidative stress, inflammation and fibrosis and improved the activity of antioxidant enzymes in MI rats. In the second study, MI-induced and sham-operated rats received vehicle, angiotensin receptor blocker/neprilysin inhibitor sacubitril/valsartan, angiotensin receptor blocker valsartan, resveratrol or sacubitril/valsartan + resveratrol for 8 weeks. Echocardiography was performed at the endpoint. Treatment with resveratrol, sacubitril/valsartan, valsartan and sacubitril/valsartan + resveratrol significantly prevented LV dilatation and improved LVEF in MI rats. Resveratrol, sacubitril/valsartan, valsartan and sacubitril/valsartan + resveratrol also significantly reduced oxidative stress, inflammation and brain natriuretic peptide in MI rats. In the final study, adult rat cardiomyocytes were pre-treated with resveratrol or left untreated and exposed to norepinephrine (NE). NE-exposure resulted in significant cardiomyocyte contractile dysfunction, reduced cell viability and an increase in oxidative stress. Resveratrol significantly improved contractile function and cell viability and reduced oxidative stress in NE-exposed adult rat cardiomyocytes. Pharmacological inhibition of superoxide dismutase (SOD) and Forkhead Box 1 (FOXO1) resulted in a loss of resveratrol mediated protection in NE-exposed adult rat cardiomyocytes. Resveratrol also prevented the proliferation of adult rat cardiac fibroblasts. In conclusion, resveratrol treatment improves cardiac structure and function equivalent to perindopril, valsartan, and sacubitril/valsartan in MI rats and the combination treatment is also effective. Resveratrol protects NE-exposed adult rat cardiomyocytes by a mechanism contingent upon SOD/FOXO1 and reduces cardiac fibroblast proliferation.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.401
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.017
GPT teacher head0.217
Teacher spread0.199 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2019
Admission routes1
Has abstractyes

Explore more

Same venueMspace (University of Manitoba)Same topicAdvancements in Semiconductor Devices and Circuit DesignFrench-language works237,207